Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

McMaster University

$20,553.00

PROSPECT Investigators Planning Meeting 2016

EF 2015-16

Résumé
According to the World Health Organization, probiotics are 'commercially available live bacteria thought to have health benefits when ingested'. Our literature review of probiotic studies in the intensive care unit (ICU) found that if patients needing a breathing machine receive probiotics, there is a 25% reduction in the serious lung infection, known as ventilator-associated pneumonia. Probiotics are also associated with an 18% reduction in the chance of developing any serious infection in the ICU. In other settings, probiotics reduce antibiotic-associated diarrhea and potentially fatal Clostridium difficile bowel infections. By decreasing the risk of infection in the ICU, probiotics may also help to avoid over-use of antibiotics which can breed antibiotic-resistant organisms that are extremely difficult to treat. Overall, whether probiotics are really helpful or not is unclear in critically ill patients because the studies are of small and of poor quality. After recently completing a pilot study to show that a large study is feasible, we are now starting a large global trial. This will evaluate the effects of probiotics in critical illness, investigating whether Lactobacillus rhamnosus GG (a common probiotic found in yoghurt) prevents pneumonia and other serious infections such as Clostridium difficile bowel infections, and whether it reduces unnecessary antibiotic use which predisposes to resistant organisms. This grant will fund a 1 day meeting of basic, clinical and health services researchers, and other important stakeholders in Halifax, Nova Scotia on June 13, 2016. The overall goals are to carefully review the pilot study results and lessons learned, design additional biological and economic studies to evaluate whether probiotics are an effective, safe, and inexpensive way to prevent serious infections in critically ill patients and plan the optimal implementation of the large international trial.
Programme
Planning and Dissemination Grant - Institute Community Support
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
334748
Name
Cook Deborah J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Not applicable / Specified
Prcname2
Planning and Dissemination - ICRH
Projecttitle
PROSPECT Investigators Planning Meeting 2016
Programtype2
Miscellaneous Programs
Orgnameinp2
McMaster University
Cihramount2
$20,553
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Clostridium Difficile; Critically Ill; Infection; International; Investigator Meeting; Probiotics; Ventilator Associated Pnemonia
Abstract
According to the World Health Organization, probiotics are 'commercially available live bacteria thought to have health benefits when ingested'. Our literature review of probiotic studies in the intensive care unit (ICU) found that if patients needing a breathing machine receive probiotics, there is a 25% reduction in the serious lung infection, known as ventilator-associated pneumonia. Probiotics are also associated with an 18% reduction in the chance of developing any serious infection in the ICU. In other settings, probiotics reduce antibiotic-associated diarrhea and potentially fatal Clostridium difficile bowel infections. By decreasing the risk of infection in the ICU, probiotics may also help to avoid over-use of antibiotics which can breed antibiotic-resistant organisms that are extremely difficult to treat. Overall, whether probiotics are really helpful or not is unclear in critically ill patients because the studies are of small and of poor quality. After recently completing a pilot study to show that a large study is feasible, we are now starting a large global trial. This will evaluate the effects of probiotics in critical illness, investigating whether Lactobacillus rhamnosus GG (a common probiotic found in yoghurt) prevents pneumonia and other serious infections such as Clostridium difficile bowel infections, and whether it reduces unnecessary antibiotic use which predisposes to resistant organisms. This grant will fund a 1 day meeting of basic, clinical and health services researchers, and other important stakeholders in Halifax, Nova Scotia on June 13, 2016. The overall goals are to carefully review the pilot study results and lessons learned, design additional biological and economic studies to evaluate whether probiotics are an effective, safe, and inexpensive way to prevent serious infections in critically ill patients and plan the optimal implementation of the large international trial.
Competitiondate
201508
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cook, Deborah J
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $9,977~ $0~Inst of Infection & Immunity~ $10,576~ $0~